TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -3 | 2 | 5 | -13 | -23 | -26 | -10 |
| S | %wins | 100 | 50 | 50 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/2/05 14:42 | 2/1/05 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rauch Alan Mark | UT | O | VP,Chief | S | -19 | 16.04 | 9 | -1 | -82 | 0 | D | -28 | -52 | -9 | -5 | -11 | -9 | -4 | -5 | -2 | -7 | -13 | -23 | -31 | -10 |
8/11/04 17:12 | 8/11/04 | NPSP | Nps Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rauch Alan Mark | UT | O | VP,Chief | S | -13 | 17.75 | 11 | -1 | -94 | 0 | D | -24 | -24 | -46 | -20 | -17 | -3 | -7 | -1 | -3 | 10 | 22 | -3 | -14 | -41 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |